Open AccessEffect of itopride, a new prokinetic, in patients with mild GERD: A pilot study
Author(s) -
YongSung Kim,
Tae Hyeon Kim,
Chang Soo Choi,
Young Woo Shon,
Sang Wook Kim,
Geom Seog Seo,
Yong Ho Nah,
Myung Gyu Choi,
Suck Chei Choi
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i27.4210
Subject(s) - gerd , gastroenterology , medicine , reflux , ambulatory , prokinetic agent , esophagitis , adverse effect , esophagus , disease
Itopride is a newly developed prokinetic agent, which enhances gastric motility through both antidopaminergic and anti-acetylcholinesterasic actions. The importance of esophageal motor dysfunction in the pathogenesis of gastro-esophageal reflux disease (GERD) makes it interesting to examine the effect of itopride on esophageal acid exposure.